Literature DB >> 9605406

Identification of receptors and Smad proteins involved in activin signalling in a human epidermal keratinocyte cell line.

A Shimizu1, M Kato, A Nakao, T Imamura, P ten Dijke, C H Heldin, M Kawabata, S Shimada, K Miyazono.   

Abstract

BACKGROUND: Activin A is a multifunctional protein, which is a member of the transforming growth factor-beta (TGF-beta) superfamily. Smad proteins have recently been shown to transduce signals for the TGF-beta superfamily of proteins, and Smad2 was implicated in activin signalling in Xenopus embryos.
RESULTS: We identified the receptors and Smad proteins activated by activin A in a human epidermal keratinocyte cell line, HaCaT. The major activin receptors expressed on HaCaT cells were activin type II receptor (ActR-II) and activin type IB receptor (ActR-IB). We have also shown that in HaCaT cells, activin A induced the phosphorylation of Smad3 and, to a lesser extent, of Smad2. On the other hand, TGF-beta induced an efficient phosphorylation of both Smad2 and Smad3. Activin A preferentially induced the nuclear translocation of Smad3 in HaCaT cells, whereas TGF-beta strongly induced the nuclear translocation of Smad2, as well as other Smads. Moreover, a constitutively active form of ActR-IB efficiently stimulated the formation of a heteromeric complex between Smad3 and Smad4 in COS cells transfected with Smad cDNAs.
CONCLUSIONS: These results suggest that activin A binds to a receptor complex of ActR-II and ActR-IB, and preferentially activates Smad3 in HaCaT human keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9605406     DOI: 10.1046/j.1365-2443.1998.00174.x

Source DB:  PubMed          Journal:  Genes Cells        ISSN: 1356-9597            Impact factor:   1.891


  13 in total

1.  The fibroblast integrin alpha11beta1 is induced in a mechanosensitive manner involving activin A and regulates myofibroblast differentiation.

Authors:  Sergio Carracedo; Ning Lu; Svetlana N Popova; Roland Jonsson; Beate Eckes; Donald Gullberg
Journal:  J Biol Chem       Date:  2010-02-02       Impact factor: 5.157

2.  Overexpression of Smad2 and colocalization with TGF-beta1 in human pancreatic cancer.

Authors:  J Kleeff; H Friess; P Simon; S Susmallian; P Büchler; A Zimmermann; M W Büchler; M Korc
Journal:  Dig Dis Sci       Date:  1999-09       Impact factor: 3.199

3.  Impaired wound healing in transgenic mice overexpressing the activin antagonist follistatin in the epidermis.

Authors:  M Wankell; B Munz; G Hübner; W Hans; E Wolf; A Goppelt; S Werner
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

Review 4.  Cell-type specific modulation of pituitary cells by activin, inhibin and follistatin.

Authors:  Louise M Bilezikjian; Nicholas J Justice; Alissa N Blackler; Ezra Wiater; Wylie W Vale
Journal:  Mol Cell Endocrinol       Date:  2012-02-04       Impact factor: 4.102

5.  Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentration-dependent manner via keratinocytes.

Authors:  Casimir Bamberger; Agnes Schärer; Maria Antsiferova; Birte Tychsen; Sandra Pankow; Mischa Müller; Thomas Rülicke; Ralf Paus; Sabine Werner
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

6.  Smad3 deficiency reduces neurogenesis in adult mice.

Authors:  Yu Wang; Aviva J Symes
Journal:  J Mol Neurosci       Date:  2010-02-13       Impact factor: 3.444

7.  Dorsomorphin inhibits BMP signals required for embryogenesis and iron metabolism.

Authors:  Paul B Yu; Charles C Hong; Chetana Sachidanandan; Jodie L Babitt; Donna Y Deng; Stefan A Hoyng; Herbert Y Lin; Kenneth D Bloch; Randall T Peterson
Journal:  Nat Chem Biol       Date:  2007-11-18       Impact factor: 15.040

8.  Neuronal and astroglial TGFβ-Smad3 signaling pathways differentially regulate dendrite growth and synaptogenesis.

Authors:  Chuan-Yong Yu; Wei Gui; Hui-Yan He; Xiao-Shan Wang; Jian Zuo; Lin Huang; Nong Zhou; Kai Wang; Yu Wang
Journal:  Neuromolecular Med       Date:  2014-02-13       Impact factor: 3.843

9.  Role of follistatin in promoting adipogenesis in women.

Authors:  John N Flanagan; Kristina Linder; Niklas Mejhert; Elisabeth Dungner; Kerstin Wahlen; Pauline Decaunes; Mikael Rydén; Peyman Björklund; Stefan Arver; Shalender Bhasin; Anne Bouloumie; Peter Arner; Ingrid Dahlman
Journal:  J Clin Endocrinol Metab       Date:  2009-05-26       Impact factor: 5.958

10.  BMP type I receptor inhibition reduces heterotopic [corrected] ossification.

Authors:  Paul B Yu; Donna Y Deng; Carol S Lai; Charles C Hong; Gregory D Cuny; Mary L Bouxsein; Deborah W Hong; Patrick M McManus; Takenobu Katagiri; Chetana Sachidanandan; Nobuhiro Kamiya; Tomokazu Fukuda; Yuji Mishina; Randall T Peterson; Kenneth D Bloch
Journal:  Nat Med       Date:  2008-11-30       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.